- In April 2023, Baxter International Inc., a global leader in renal care, announced the launch of an AI-powered fluid management platform designed to support early detection of acute oliguria and acute kidney injury (AKI) in ICU settings. The system integrates real-time urine output monitoring with predictive analytics to guide clinical decision-making. This development emphasizes Baxter’s commitment to enhancing patient outcomes through intelligent and data-driven renal care solutions
- In March 2023, Fresenius Medical Care unveiled an advanced portable renal diagnostic device aimed at early identification of fluid imbalances and oliguria in both inpatient and outpatient environments. Designed to support decentralized monitoring, the device empowers clinicians in rural or resource-limited settings with accurate, real-time data. The launch highlights Fresenius’s strategy to expand access to innovative nephrology tools globally
- In March 2023, RenalSense Ltd. partnered with several U.S. hospitals to deploy its Clarity RMS platform—an advanced real-time urine monitoring system—across intensive care units. The system enhances detection of oliguria and optimizes fluid management in critically ill patients. This partnership reflects RenalSense’s mission to digitize renal diagnostics and improve clinical efficiency in high-acuity environments
- In February 2023, Medtronic initiated a multi-center clinical study evaluating the efficacy of AI-supported early warning systems for oliguria and AKI in post-operative care units. The study aims to validate real-time alert tools that notify care teams of deteriorating renal function, enhancing preventive interventions. The trial underlines Medtronic’s investment in proactive kidney health technologies
- In January 2023, Nihon Kohden launched a next-generation ICU monitoring suite in Japan, featuring integrated urine output sensors and renal function tracking modules. This system enables seamless monitoring of oliguria alongside other vital signs, improving workflow and care continuity. The innovation supports Nihon Kohden’s commitment to intelligent and comprehensive critical care solutions tailored to an aging and high-risk population
